<--- Back to Details
First PageDocument Content
Endocrine diseases / Osteopathies / Osteoporosis / Parathyroid hormone / Bone remodeling / Meta-analysis / Nephrology / Calcitriol / Osteitis fibrosa cystica / Health / Endocrine system / Anatomy
Date: 2015-03-04 12:53:48
Endocrine diseases
Osteopathies
Osteoporosis
Parathyroid hormone
Bone remodeling
Meta-analysis
Nephrology
Calcitriol
Osteitis fibrosa cystica
Health
Endocrine system
Anatomy

Microsoft PowerPoint - PO4_Bone_Mineral_PD_Burkart_REVISED.6.jb.md]

Add to Reading List

Source URL: ispd.org

Download Document from Source Website

File Size: 768,10 KB

Share Document on Facebook

Similar Documents

Preventing Falls * Persons with developmental disabilities may be at increased risk for falls due to things such as cerebral palsy, osteoporosis, epilepsy and some medications.

DocID: 1vgLN - View Document

NEWS RELEASE NEWS RELEASE NEWS RELEASE NEWS RELEASE NEWS RELEASE Contact: (SUNSWEET GROWERS TO RETURN AS OFFICIAL SPONSOR OF WORLD OSTEOPOROSIS DAY Sunsweet Promotes the Positive Role o

DocID: 1vd0S - View Document

Master’s Thesis Proposal Damage Morphology in Compact Bone Associated with Distinct Loading Modes Background An annual prevalence of 1.6 million osteoporosis related hip fractures, constitutes a major sociomedical cha

DocID: 1v0QH - View Document

Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses Newmg/day Minivelle,

DocID: 1ufoU - View Document

New Minivelle® (Estradiol Transdermal Systemmg/day Dose Now Available by Prescription in U.S. Pharmacies New dose approved by FDA for the prevention of postmenopausal osteoporosis only; higher doses of Minivelle

DocID: 1u26h - View Document